News on qPCR, digital PCR, amplification, point-of-care testing platforms in genetics, genomics, and molecular diagnostics.
Stilla Technologies, Atila BioSystems Partner to Codevelop Liquid Biopsy Digital PCR Kits
The firms will comarket kits produced by Atila for Stilla's Naica system to detect circulating tumor DNA in liquid biopsy samples from patients with common cancers.
Rapid Pathogen ID/AST Market Begins to Recover Post-COVID as Drug-Resistant Infections Spike
Although bacterial and fungal drug resistance rates increased during the pandemic, a heavy focus on COVID testing has slowed adoption of novel ID/AST technologies.
BGI Genomics, Zentya Partner to Launch PCR Fecal Test for Colorectal Cancer in Slovakia
ColoTect 1.0 is a fecal assay that can trace abnormal colorectal cancer DNA-methylation biomarkers from fecal samples using methylation-specific PCR technology.
Todos Medical Subsidiary Inks US Commercialization Deal for Acumen Diagnostics Sepsis PCR Test
Todos Medical acquired the subsidiary, Provista Diagnostics, in early 2021 from Ascenda Biosciences for $7.5 million in cash and stock.
Amoy Diagnostics PLC Panel Gets Approval in Japan as CDx for Retevmo in Non-Small Cell Lung Cancer
Oncologists in Japan can now use the AmoyDx Pan Lung Cancer PCR Panel to identify patients with RET fusions that make them eligible for treatment with the Eli Lilly drug.